DRUG DESCRIPTION. LEVEMIRÂ® (insulin detemir [rDNA origin] injection) is a sterile solution of insulin detemir for use as a subcutaneous injection. Insulin detemir is a long-acting (up to 24-hour duration of action) recombinant human insulin analog. LEVEMIRÂ® is produced by a process that includes expression of recombinant DNA in Saccharomyces cerevisiae followed by chemical modification.
The UV Index is a linear scale, with higher values representing a greater risk of sunburn (which is correlated with other health risks) due to UV exposure. An index of 0 corresponds to zero UV radiation, as is essentially the case at night.
UVB ranges from 290 to 320 nm. With even shorter rays, most UVC is absorbed by the ozone layer and does not reach the earth. Both UVA and UVB, however, penetrate the atmosphere and play an important role in conditions such as premature skin aging, eye damage (including cataracts), and skin cancers.